Literature DB >> 26898405

Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus.

Claudio Celentano1, Barbara Matarrelli2, Peter A Mattei3, Giulia Pavone4, Ester Vitacolonna5, Marco Liberati6.   

Abstract

Gestational diabetes mellitus (GDM) is a common complication characterized by increased insulin resistance, and by increased risk for adverse pregnancy outcomes affecting both the mother and the fetus. International guidelines describe optimal ways to recognize it, and the recommended treatment of patients affected to reduce adverse outcomes. Improving insulin resistance could reduce incidence of GDM and its complications. Recently, a few trials have been published on the possible prevention of GDM. Inositol has been proposed as a food supplement that might reduce gestational diabetes incidence in high-risk pregnant women.

Entities:  

Keywords:  Adverse pregnancy outcome; Gestational diabetes mellitus; Insulin resistance; Myo-inositol; Prevention

Mesh:

Substances:

Year:  2016        PMID: 26898405     DOI: 10.1007/s11892-016-0726-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  29 in total

1.  Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys.

Authors:  H K Ortmeyer; J Larner; B C Hansen
Journal:  Obes Res       Date:  1995-11

2.  Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.

Authors:  Charles J Glueck; Joel Pranikoff; Dawit Aregawi; Ping Wang
Journal:  Fertil Steril       Date:  2007-08-06       Impact factor: 7.329

3.  Myo-inositol in the treatment of premenstrual dysphoric disorder.

Authors:  Carlomagno Gianfranco; Unfer Vittorio; Buffo Silvia; D'Ambrosio Francesco
Journal:  Hum Psychopharmacol       Date:  2011-10       Impact factor: 1.672

4.  Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation.

Authors:  Zhijie Dai; Sookja K Chung; Dengshun Miao; Kam S Lau; Alfred W H Chan; Annie W C Kung
Journal:  J Bone Miner Res       Date:  2011-03       Impact factor: 6.741

Review 5.  Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.

Authors:  V Unfer; G Carlomagno; G Dante; F Facchinetti
Journal:  Gynecol Endocrinol       Date:  2012-02-01       Impact factor: 2.260

6.  One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome.

Authors:  A Santamaria; D Giordano; F Corrado; B Pintaudi; M L Interdonato; G Di Vieste; A Di Benedetto; R D'Anna
Journal:  Climacteric       Date:  2011-12-23       Impact factor: 3.005

7.  Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines.

Authors:  Wan T Teh; Helena J Teede; Eldho Paul; Cheryce L Harrison; Euan M Wallace; Carolyn Allan
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-02       Impact factor: 2.100

Review 8.  Second messengers of insulin action.

Authors:  A R Saltiel
Journal:  Diabetes Care       Date:  1990-03       Impact factor: 19.112

9.  Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.

Authors:  Ryouta Maeba; Hiroshi Hara; Hiroshi Ishikawa; Shigeru Hayashi; Nakayuki Yoshimura; Jyun Kusano; Yoko Takeoka; Daijiro Yasuda; Tomoki Okazaki; Makoto Kinoshita; Tamio Teramoto
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  2008-06       Impact factor: 2.000

10.  Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.

Authors:  Rosario D'Anna; Antonino Di Benedetto; Angela Scilipoti; Angelo Santamaria; Maria Lieta Interdonato; Elisabetta Petrella; Isabella Neri; Basilio Pintaudi; Francesco Corrado; Fabio Facchinetti
Journal:  Obstet Gynecol       Date:  2015-08       Impact factor: 7.661

View more
  5 in total

1.  Myoinositol and D-Chiro Inositol in Improving Insulin Resistance in Obese Male Children: Preliminary Data.

Authors:  Mario Mancini; Alice Andreassi; Michela Salvioni; Fiore Pelliccione; Gianna Mantellassi; Giuseppe Banderali
Journal:  Int J Endocrinol       Date:  2016-11-01       Impact factor: 3.257

2.  Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.

Authors:  Vittorio Unfer; Fabio Facchinetti; Beatrice Orrù; Barbara Giordani; John Nestler
Journal:  Endocr Connect       Date:  2017-11       Impact factor: 3.335

Review 3.  Isolation, Separation, and Preconcentration of Biologically Active Compounds from Plant Matrices by Extraction Techniques.

Authors:  Victoria Raks; Hossam Al-Suod; Bogusław Buszewski
Journal:  Chromatographia       Date:  2017-09-22       Impact factor: 2.044

4.  Activation of eNOS by D-pinitol Induces an Endothelium-Dependent Vasodilatation in Mouse Mesenteric Artery.

Authors:  Luciana N Moreira; Josiane F Silva; Grazielle C Silva; Virgínia S Lemos; Steyner F Cortes
Journal:  Front Pharmacol       Date:  2018-05-22       Impact factor: 5.810

Review 5.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions.

Authors:  Antonio Aversa; Sandro La Vignera; Rocco Rago; Alessandra Gambineri; Rossella E Nappi; Aldo E Calogero; Alberto Ferlin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.